| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |